Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
61 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Organogenesis Holdings Inc.’s names, not what it holds today.
Patents granted
61
61 utility, 1976 to Dec 31, 2025
Granted in 2025
4
Against 2 in 2024 and 1 in 2023
Applications published
33
1 of them in 2025
Names they are printed under
4
a subsidiary
By yearGrantedApplications published
'07'08'09'10'11'12'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals9
Medical technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Organogenesis Inc. a subsidiary
US, as the owner printed on each patent
23 publishedPrime Merger Sub, LLC a subsidiary
US, as the owner printed on each patent
0 publishedPrime Merger Sub, LLC a subsidiary
named as the applicant on its applications, in US
7 publishedOrganogenesis, Inc. a subsidiary
named as the applicant on its applications, in US
3 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 23, 2025 | 12,501,893 | Method and composition for hypothermic storage of placental tissue | Pharmaceuticals | Prime Merger Sub, LLC |
| Nov 18, 2025 | 12,472,238 | Porcine collagen compositions and methods of use thereof | Pharmaceuticals | Organogenesis Inc. |
| Oct 7, 2025 | 12,433,918 | Methods of treating joint disease, disorders, and conditions with tissue inhibitors of matrix metalloproteinase | Pharmaceuticals | Prime Merger Sub, LLC |
| Aug 12, 2025 | 12,383,582 | Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases | Pharmaceuticals | Prime Merger Sub, LLC |
| Nov 26, 2024 | 12,150,445 | Method and composition for hypothermic storage of placental tissue | Pharmaceuticals | Prime Merger Sub, LLC |
| Feb 13, 2024 | 11,896,623 | Visco-supplement compositions, and methods of use thereof | Pharmaceuticals | Prime Merger Sub, LLC |
| Jun 6, 2023 | 11,666,606 | Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases | Pharmaceuticals | Prime Merger Sub, LLC |
| Nov 8, 2022 | 11,491,190 | Visco-supplement compositions, and methods of use thereof | Pharmaceuticals | Prime Merger Sub, LLC |
| Sep 28, 2021 | 11,129,856 | Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases | Pharmaceuticals | Prime Merger Sub, LLC |
| Aug 10, 2021 | 11,083,758 | Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs | Medical technology | Prime Merger Sub, LLC |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Aug 21, 2025 | 2025/0262250 | METHOD OF TREATING PAIN ASSOCIATED WITH A CARTILAGE DEFECT | Medical technology | Prime Merger Sub, LLC |
| Feb 22, 2024 | 2024/0058391 | METHODS OF TREATING JOINT DISEASE, DISORDERS, AND CONDITIONS WITH TISSUE INHIBITORS OF MATRIX METALLOPROTEINASE | Pharmaceuticals | Prime Merger Sub, LLC · patent 12,433,918 granted from it |
| Jan 25, 2024 | 2024/0024429 | Porcine Collagen Compositions and Methods of Use Thereof | Pharmaceuticals | Organogenesis, Inc. · patent 12,472,238 granted from it |
| Feb 10, 2022 | 2022/0040378 | WOUND CARE TREATMENT AND METHODS OF MAKING AND USING SAME | Medical technology | Prime Merger Sub, LLC |
| Dec 23, 2021 | 2021/0393702 | METHODS OF TREATING CHRONIC WOUNDS WITH AMNIOTIC FLUID HAVING ELEVATED LEVELS OF TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES | Pharmaceuticals | Prime Merger Sub, LLC · patent 12,383,582 granted from it |
| Oct 28, 2021 | 2021/0330714 | Placental Membrane Preparations and Methods of Making and Using Same for Regenerating Cartilage and Spinal Intervertebral Discs | Medical technology | Prime Merger Sub, LLC |
| Oct 7, 2021 | 2021/0311022 | METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT | Analysis of biological materials | Organogenesis, Inc. |
| Nov 12, 2020 | 2020/0353013 | VISCO-SUPPLEMENT COMPOSITIONS, AND METHODS OF USE THEREOF | Pharmaceuticals | Prime Merger Sub, LLC · patent 11,491,190 granted from it |
| May 14, 2020 | 2020/0147144 | METHODS OF TREATING JOINT DISEASE, DISORDERS AND CONDITIONS WITH TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES | Pharmaceuticals | Prime Merger Sub, LLC · patent 11,666,606 granted from it |
| Aug 2, 2018 | 2018/0214606 | ORAL TISSUE REGENERATION AND REPAIR | Medical technology | Organogenesis, Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 2 · Medical technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.